614
Participants
Start Date
October 9, 2021
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2035
GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX)
Intent to treat with the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX) in the treatment of Peripheral Artery Disease as part of routine clinical practice.
RECRUITING
iD3 Medical cvba, Sint-Agatha-Berchem
RECRUITING
Ospedale San Giovanni Molinette, Torino
RECRUITING
Dipartimento di Scienze Chirurgiche e Morfologiche, Varese
RECRUITING
Krankenhaus Reinbek St. Adolf-Stift, Reinbek
RECRUITING
Marien Krankenhaus, Hamburg
RECRUITING
Fondazione Poliambulanza, Brescia
RECRUITING
Centre Hospitalier Regional Universitaire de Brest, Brest
RECRUITING
Alvaro Cunqueiro Hospital, Vigo
RECRUITING
S.C. Chirurgia Vascolare dell'A.O.U. di Modena, Modena
RECRUITING
Centre Hospitalier Unversitaire d'Angers, Angers
RECRUITING
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona
RECRUITING
Cardioangiologisches Centrum Bethanien, Frankfurt
RECRUITING
Clinique RHENA, Strasbourg
RECRUITING
Hopital Edouard Herriot (HCL), Lyon
RECRUITING
University Hospital Tuebingen, Tübingen
RECRUITING
Hospital Paris Saint-Joseph, Paris
RECRUITING
University of Heidelberg, Heidelberg
WITHDRAWN
Saarland University Medical Center, Homburg
RECRUITING
Papageorgiou Hospital, Pávlos
RECRUITING
Rijnstate, Arnhem
RECRUITING
Medical Center Leeuwarden, Leeuwarden
RECRUITING
Hospital Universitari Germans Trias i Pujol, Barcelona
RECRUITING
Skane University Hospital, Malmo
RECRUITING
Karolinska University Hospital, Solna
RECRUITING
Southmead Hospital, Bristol
RECRUITING
Greater Glasgow Health Board, Glasgow
RECRUITING
Queen Elizabeth Hospital, London
W.L.Gore & Associates
INDUSTRY